THC concentrations in oral fluid peaked during or immediately after cannabis consumption regardless of route, but smoked and vaporized cannabis produced significantly higher THC peaks than edibles, while edibles created wider detection windows for metabolites.
Readers who may face saliva-based cannabis testing or are interested in detection science.
Smoked/vaporized cannabis: higher saliva THC peaks. Edibles: longer metabolite detection windows
What the researchers found
This controlled study compared oral fluid (saliva) pharmacokinetics after three routes of cannabis administration: smoking, vaporizing, and oral (brownie) consumption.
Peak THC in saliva occurred during or immediately after consumption for all routes, driven by direct oral mucosa contamination from inhaled smoke/vapor or the brownie itself. Smoked and vaporized cannabis produced significantly higher peak THC concentrations than oral consumption in frequent smokers.
For occasional smokers, a key difference emerged: oral (edible) dosing produced more positive results for the metabolites 11-OH-THC and THCCOOH than inhaled routes, widening the detection window. This means edible users might test positive for metabolites longer than smokers.
The researchers also identified that THCV and CBG at very low cutoff levels (0.3 micrograms per liter) could serve as markers of recent cannabis use, as these minor cannabinoids clear from saliva relatively quickly.
Why it matters
Oral fluid testing is increasingly used for roadside cannabis detection and workplace testing. Understanding how different consumption methods affect what shows up in saliva, and for how long, is critical for interpreting test results fairly. The finding that edibles create different detection patterns than smoking has practical implications for both users and law enforcement.
The numbers in context
Cannabis dose: 6.9% THC. Oral fluid collected up to 54-72 hours post-dose. Six cannabinoids measured: THC, 11-OH-THC, THCCOOH, THCV, CBD, CBG. Smoked/vaporized: higher peak THC. Oral: more metabolite-positive specimens. THCV and CBG at 0.3 micrograms/L: markers of recent use.
How the study worked
Controlled dosing study with frequent and occasional cannabis smokers. Each participant completed four sessions: active brownie + placebo cigarette, placebo brownie + active cigarette, active vaporized dose, or placebo vaporized dose. Only one active dose (6.9% THC) per session. Oral fluid collected up to 54-72 hours post-dose. Six cannabinoids quantified by LC-MS/MS.
What this study cannot tell us
Small study size (numbers not specified in abstract). Only one THC concentration tested (6.9%). The cannabis market now includes products with much higher THC levels. Oral fluid pharmacokinetics can vary significantly between individuals based on salivary flow, oral pH, and other factors. CBD-dominant products were not tested.
How to read the evidence
Moderate evidence from a controlled pharmacokinetic study with multiple dosing routes and detailed cannabinoid analysis.
When this study was published
Published in 2017. Oral fluid testing technology and cutoff standards continue to evolve.
The bigger picture
As cannabis policy evolves, testing technology must keep pace with changing consumption patterns. The shift toward edibles in legal markets means that testing protocols developed for smoked cannabis may not perform the same way. This study provides foundational pharmacokinetic data for improving oral fluid testing protocols.
Questions still open
- How do higher-potency products affect oral fluid detection windows? Could THCV and CBG cutoffs be standardized for determining recent versus past use? How should roadside testing protocols account for edible versus smoked cannabis?
Common questions
How long can THC be detected in saliva?
Does eating cannabis versus smoking it affect drug test results?
Read the original research
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
Drug testing and analysis, 9(6), 905-915
Citation
Swortwood, Madeleine J; Newmeyer, Matthew N; Andersson, Maria; Abulseoud, Osama A; Scheidweiler, Karl B; Huestis, Marilyn A. (2017). Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.. Drug testing and analysis, 9(6), 905-915. https://doi.org/10.1002/dta.2092